Growth Metrics

Innoviva (INVA) Interest Coverage Ratio (QoQ) (2010 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -17.62%
Jun 30, 2025 18.89%
Sep 30, 2024 -21.00%
Jun 30, 2024 639.19%
Sep 30, 2023 989.79%
Jun 30, 2023 14.26%
Sep 30, 2022 100.04%
Jun 30, 2022 13.47%
Sep 30, 2021 -2.98%
Jun 30, 2021 1,857.17%
Mar 31, 2021 16.55%
Dec 31, 2020 -107.56%
Sep 30, 2020 10.38%
Jun 30, 2020 -1.41%
Mar 31, 2020 7.32%
Dec 31, 2019 21.23%
Sep 30, 2019 1.03%
Jun 30, 2019 13.47%
Mar 31, 2019 -32.97%
Dec 31, 2018 53.13%
Sep 30, 2018 13.78%
Jun 30, 2018 82.04%
Mar 31, 2018 192.06%
Dec 31, 2017 -71.04%
Sep 30, 2017 60.34%
Jun 30, 2017 70.71%
Mar 31, 2017 -20.75%
Dec 31, 2016 35.97%
Sep 30, 2016 8.32%
Jun 30, 2016 47.61%
Mar 31, 2016 0.53%
Dec 31, 2015 105.29%
Sep 30, 2015 64.15%
Jun 30, 2015 570.80%
Mar 31, 2015 466.76%
Dec 31, 2014 101.34%
Sep 30, 2014 18.57%
Jun 30, 2014 89.41%
Mar 31, 2014 -103.57%
Dec 31, 2013 -8.57%
Sep 30, 2013 -77.70%
Jun 30, 2013 81.31%
Mar 31, 2013 56.55%
Dec 31, 2012 -26.32%
Sep 30, 2012 6.54%
Jun 30, 2012 -141.53%
Mar 31, 2012 342.02%
Dec 31, 2011 -21.99%
Sep 30, 2011 -23.52%
Jun 30, 2011 -11.35%
Mar 31, 2011 -18.55%
Dec 31, 2010 9.27%
Sep 30, 2010 -1.79%